Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments

@inproceedings{Schooling2018DisconnectBG,
  title={Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments},
  author={C. Mary Schooling and J. V. Huang and J. V. Zhao and M. K. Kwok and S L Au Yeung and S. L. Lin},
  booktitle={EBioMedicine},
  year={2018}
}
BACKGROUND Development of pharmacological treatments to mitigate ischemic heart disease (IHD) has encompassed disappointing results and expensive failures, which has discouraged investment in new approaches to prevention and control. New treatments are most likely to be successful if they act on genetically validated targets. We assessed whether existing pharmacological treatments for IHD reduction are acting on genetically validated targets and whether all such targets for IHD are currently… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 39 REFERENCES

Data, information, knowledge and principle: back to metabolism in KEGG

  • Nucleic Acids Research
  • 2014
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

DrugBank: a knowledgebase for drugs, drug actions and drug targets

  • Nucleic Acids Research
  • 2008
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL